A Comparative Clinical trial to Evaluate the Efficacy and Tolerability of Troxipide in the treatment of gastritis and/or gastric ulcer disease.
Phase 4
Completed
- Conditions
- Health Condition 1: K290- Acute gastritisHealth Condition 2: K294- Chronic atrophic gastritis
- Registration Number
- CTRI/2012/12/003264
- Lead Sponsor
- Zuventus Healthcare Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1.Male or female patients aged 18 years or older.
2.Clinical symptoms and endoscopic diagnosis of gastric mucosal injury (erosion/ oozing/redness/edema) as in gastritis (acute or acute exacerbation of chronic gastritis) and/or gastric ulcers (Patients with endoscopically diagnosed A1- or A2-stage ulcer (by Sakita/Miwa classification).
3.Patients willing to give written informed consent and willing to comply with trial protocol.
4.Patients who are on therapy with PPI, H2RAs, NSAIDs, muscarinic antagonists or other gastroprotective agents, but who have undergone a washout period of 7 days wherein only oral antacids are taken.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method